Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1801 to 1810 of 1810 entries
Sorted by: Best Match Show Resources per page
Importance of preserving the resident microflora of the skin to improve immunological response.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research

Rinaldi F, Giuliani G, Pinto D.
PMID: 33972384
J Investig Med. 2021 Oct;69(7):1386-1387. doi: 10.1136/jim-2021-001823. Epub 2021 May 10.

No abstract available.

Cite
Rinaldi F, Giuliani G, Pinto D. Importance of preserving the resident microflora of the skin to improve immunological response. J Investig Med. 2021;69(7):1386-1387doi: 10.1136/jim-2021-001823.
Rinaldi, F., Giuliani, G., & Pinto, D. (2021). Importance of preserving the resident microflora of the skin to improve immunological response. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 69(7), 1386-1387. https://doi.org/10.1136/jim-2021-001823
Rinaldi, Fabio, et al. "Importance of preserving the resident microflora of the skin to improve immunological response." Journal of investigative medicine : the official publication of the American Federation for Clinical Research vol. 69,7 (2021): 1386-1387. doi: https://doi.org/10.1136/jim-2021-001823
Rinaldi F, Giuliani G, Pinto D. Importance of preserving the resident microflora of the skin to improve immunological response. J Investig Med. 2021 Oct;69(7):1386-1387. doi: 10.1136/jim-2021-001823. Epub 2021 May 10. PMID: 33972384; PMCID: PMC8485132.
Copy Download .nbib Format: NLM
Cloud architecture for electronic health record systems interoperability.

Technology and health care : official journal of the European Society for Engineering and Medicine

Gómez D, Romero J, López P, Vázquez J, Cappo C, Pinto D, Villalba C.
PMID: 34511519
Technol Health Care. 2021 Sep 09; doi: 10.3233/THC-212806. Epub 2021 Sep 09.

BACKGROUND: Current Electronic Health Record (EHR) systems are built using different data representation and information models, which makes difficult achieving information exchange.OBJECTIVE: Our aim was to propose a scalable architecture that allows the integration of information from different EHR...

Cite
Gómez D, Romero J, López P, et al. Cloud architecture for electronic health record systems interoperability. Technol Health Care. 2021;doi: 10.3233/THC-212806.
Gómez, D., Romero, J., López, P., Vázquez, J., Cappo, C., Pinto, D., & Villalba, C. (2021). Cloud architecture for electronic health record systems interoperability. Technology and health care : official journal of the European Society for Engineering and Medicine, . https://doi.org/10.3233/THC-212806
Gómez, Derlis, et al. "Cloud architecture for electronic health record systems interoperability." Technology and health care : official journal of the European Society for Engineering and Medicine vol. (2021). doi: https://doi.org/10.3233/THC-212806
Gómez D, Romero J, López P, Vázquez J, Cappo C, Pinto D, Villalba C. Cloud architecture for electronic health record systems interoperability. Technol Health Care. 2021 Sep 09; doi: 10.3233/THC-212806. Epub 2021 Sep 09. PMID: 34511519.
Copy Download .nbib Format: NLM
Does the type of seizure influence heart rate variability changes?.

Epilepsy & behavior : E&B

Faria MT, Rodrigues S, Campelo M, Dias D, Rego R, Rocha H, Sá F, Tavares-Silva M, Pinto R, Pestana G, Oliveira A, Pereira J, Cunha JPS, Rocha-Gonçalves F, Gonçalves H, Martins E.
PMID: 34864377
Epilepsy Behav. 2021 Dec 01;126:108453. doi: 10.1016/j.yebeh.2021.108453. Epub 2021 Dec 01.

OBJECTIVE: Heart rate variability (HRV), an index of the autonomic cardiac activity, is decreased in patients with epilepsy, and a low HRV is associated with a higher risk of sudden death. Generalized tonic-clonic seizures are one of the most...

Cite
Faria MT, Rodrigues S, Campelo M, et al. Does the type of seizure influence heart rate variability changes?. Epilepsy Behav. 2021;126:108453doi: 10.1016/j.yebeh.2021.108453.
Faria, M. T., Rodrigues, S., Campelo, M., Dias, D., Rego, R., Rocha, H., Sá, F., Tavares-Silva, M., Pinto, R., Pestana, G., Oliveira, A., Pereira, J., Cunha, J. P. S., Rocha-Gonçalves, F., Gonçalves, H., & Martins, E. (2021). Does the type of seizure influence heart rate variability changes?. Epilepsy & behavior : E&B, 126108453. https://doi.org/10.1016/j.yebeh.2021.108453
Faria, Maria Teresa, et al. "Does the type of seizure influence heart rate variability changes?." Epilepsy & behavior : E&B vol. 126 (2021): 108453. doi: https://doi.org/10.1016/j.yebeh.2021.108453
Faria MT, Rodrigues S, Campelo M, Dias D, Rego R, Rocha H, Sá F, Tavares-Silva M, Pinto R, Pestana G, Oliveira A, Pereira J, Cunha JPS, Rocha-Gonçalves F, Gonçalves H, Martins E. Does the type of seizure influence heart rate variability changes?. Epilepsy Behav. 2021 Dec 01;126:108453. doi: 10.1016/j.yebeh.2021.108453. Epub 2021 Dec 01. PMID: 34864377.
Copy Download .nbib Format: NLM
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.

bioRxiv : the preprint server for biology

Cameroni E, Saliba C, Bowen JE, Rosen LE, Culap K, Pinto D, VanBlargan LA, De Marco A, Zepeda SK, Iulio JD, Zatta F, Kaiser H, Noack J, Farhat N, Czudnochowski N, Havenar-Daughton C, Sprouse KR, Dillen JR, Powell AE, Chen A, Maher C, Yin L, Sun D, Soriaga L, Bassi J, Silacci-Fregni C, Gustafsson C, Franko NM, Logue J, Iqbal NT, Mazzitelli I, Geffner J, Grifantini R, Chu H, Gori A, Riva A, Giannini O, Ceschi A, Ferrari P, Cippà P, Franzetti-Pellanda A, Garzoni C, Halfmann PJ, Kawaoka Y, Hebner C, Purcell LA, Piccoli L, Pizzuto MS, Walls AC, Diamond MS, Telenti A, Virgin HW, Lanzavecchia A, Veesler D, Snell G, Corti D.
PMID: 34931194
bioRxiv. 2021 Dec 20; doi: 10.1101/2021.12.12.472269.

The recently emerged SARS-CoV-2 Omicron variant harbors 37 amino acid substitutions in the spike (S) protein, 15 of which are in the receptor-binding domain (RBD), thereby raising concerns about the effectiveness of available vaccines and antibody therapeutics. Here, we...

Cite
Cameroni E, Saliba C, Bowen JE, et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. bioRxiv. 2021;doi: 10.1101/2021.12.12.472269.
Cameroni, E., Saliba, C., Bowen, J. E., Rosen, L. E., Culap, K., Pinto, D., VanBlargan, L. A., De Marco, A., Zepeda, S. K., Iulio, J. D., Zatta, F., Kaiser, H., Noack, J., Farhat, N., Czudnochowski, N., Havenar-Daughton, C., Sprouse, K. R., Dillen, J. R., Powell, A. E., Chen, A., Maher, C., Yin, L., Sun, D., Soriaga, L., Bassi, J., Silacci-Fregni, C., Gustafsson, C., Franko, N. M., Logue, J., Iqbal, N. T., Mazzitelli, I., Geffner, J., Grifantini, R., Chu, H., Gori, A., Riva, A., Giannini, O., Ceschi, A., Ferrari, P., Cippà, P., Franzetti-Pellanda, A., Garzoni, C., Halfmann, P. J., Kawaoka, Y., Hebner, C., Purcell, L. A., Piccoli, L., Pizzuto, M. S., Walls, A. C., Diamond, M. S., Telenti, A., Virgin, H. W., Lanzavecchia, A., Veesler, D., Snell, G., & Corti, D. (2021). Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2021.12.12.472269
Cameroni, Elisabetta, et al. "Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift." bioRxiv : the preprint server for biology vol. (2021). doi: https://doi.org/10.1101/2021.12.12.472269
Cameroni E, Saliba C, Bowen JE, Rosen LE, Culap K, Pinto D, VanBlargan LA, De Marco A, Zepeda SK, Iulio JD, Zatta F, Kaiser H, Noack J, Farhat N, Czudnochowski N, Havenar-Daughton C, Sprouse KR, Dillen JR, Powell AE, Chen A, Maher C, Yin L, Sun D, Soriaga L, Bassi J, Silacci-Fregni C, Gustafsson C, Franko NM, Logue J, Iqbal NT, Mazzitelli I, Geffner J, Grifantini R, Chu H, Gori A, Riva A, Giannini O, Ceschi A, Ferrari P, Cippà P, Franzetti-Pellanda A, Garzoni C, Halfmann PJ, Kawaoka Y, Hebner C, Purcell LA, Piccoli L, Pizzuto MS, Walls AC, Diamond MS, Telenti A, Virgin HW, Lanzavecchia A, Veesler D, Snell G, Corti D. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. bioRxiv. 2021 Dec 20; doi: 10.1101/2021.12.12.472269. PMID: 34931194; PMCID: PMC8687478.
Copy Download .nbib Format: NLM
The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies.

Critical reviews in oncology/hematology

Russo A, Incorvaia L, Capoluongo E, Tagliaferri P, Galvano A, Del Re M, Malapelle U, Chiari R, Conte P, Danesi R, Fassan M, Ferrara R, Genuardi M, Ghiorzo P, Gori S, Guadagni F, Marchetti A, Marchetti P, Midiri M, Normanno N, Passiglia F, Pinto C, Silvestris N, Tallini G, Vatrano S, Vincenzi B, Cinieri S, Beretta G.
PMID: 34896250
Crit Rev Oncol Hematol. 2022 Jan;169:103567. doi: 10.1016/j.critrevonc.2021.103567. Epub 2021 Dec 08.

The development of innovative technologies and the advances in the genetics and genomics, have offered new opportunities for personalized treatment in oncology. Although the selection of the patient based on the molecular characteristics of the neoplasm has the potential...

Cite
Russo A, Incorvaia L, Capoluongo E, et al. The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies. Crit Rev Oncol Hematol. 2021;169:103567doi: 10.1016/j.critrevonc.2021.103567.
Russo, A., Incorvaia, L., Capoluongo, E., Tagliaferri, P., Galvano, A., Del Re, M., Malapelle, U., Chiari, R., Conte, P., Danesi, R., Fassan, M., Ferrara, R., Genuardi, M., Ghiorzo, P., Gori, S., Guadagni, F., Marchetti, A., Marchetti, P., Midiri, M., Normanno, N., Passiglia, F., Pinto, C., Silvestris, N., Tallini, G., Vatrano, S., Vincenzi, B., Cinieri, S., & Beretta, G. (2022). The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies. Critical reviews in oncology/hematology, 169103567. https://doi.org/10.1016/j.critrevonc.2021.103567
Russo, Antonio, et al. "The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies." Critical reviews in oncology/hematology vol. 169 (2022): 103567. doi: https://doi.org/10.1016/j.critrevonc.2021.103567
Russo A, Incorvaia L, Capoluongo E, Tagliaferri P, Galvano A, Del Re M, Malapelle U, Chiari R, Conte P, Danesi R, Fassan M, Ferrara R, Genuardi M, Ghiorzo P, Gori S, Guadagni F, Marchetti A, Marchetti P, Midiri M, Normanno N, Passiglia F, Pinto C, Silvestris N, Tallini G, Vatrano S, Vincenzi B, Cinieri S, Beretta G. The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies. Crit Rev Oncol Hematol. 2022 Jan;169:103567. doi: 10.1016/j.critrevonc.2021.103567. Epub 2021 Dec 08. PMID: 34896250.
Copy Download .nbib Format: NLM
Subthalamic stimulation breaks the balance between distal and axial signs in Parkinson's disease.

Scientific reports

Atkinson-Clement C, Cavazzini É, Zénon A, Legou T, Witjas T, Fluchère F, Azulay JP, Baunez C, Pinto S, Eusebio A.
PMID: 34750479
Sci Rep. 2021 Nov 08;11(1):21810. doi: 10.1038/s41598-021-01386-0.

In Parkinson's disease (PD), the effects of both L

Cite
Atkinson-Clement C, Cavazzini É, Zénon A, et al. Subthalamic stimulation breaks the balance between distal and axial signs in Parkinson's disease. Sci Rep. 2021;11(1):21810doi: 10.1038/s41598-021-01386-0.
Atkinson-Clement, C., Cavazzini, �. �., Zénon, A., Legou, T., Witjas, T., Fluchère, F., Azulay, J. P., Baunez, C., Pinto, S., & Eusebio, A. (2021). Subthalamic stimulation breaks the balance between distal and axial signs in Parkinson's disease. Scientific reports, 11(1), 21810. https://doi.org/10.1038/s41598-021-01386-0
Atkinson-Clement, Cyril, et al. "Subthalamic stimulation breaks the balance between distal and axial signs in Parkinson's disease." Scientific reports vol. 11,1 (2021): 21810. doi: https://doi.org/10.1038/s41598-021-01386-0
Atkinson-Clement C, Cavazzini É, Zénon A, Legou T, Witjas T, Fluchère F, Azulay JP, Baunez C, Pinto S, Eusebio A. Subthalamic stimulation breaks the balance between distal and axial signs in Parkinson's disease. Sci Rep. 2021 Nov 08;11(1):21810. doi: 10.1038/s41598-021-01386-0. PMID: 34750479; PMCID: PMC8575789.
Copy Download .nbib Format: NLM
Clinical, Serological, Whole Genome Sequence Analyses to Confirm SARS-CoV-2 Reinfection in Patients From Mumbai, India.

Frontiers in medicine

Shastri J, Parikh S, Agrawal S, Chatterjee N, Pathak M, Chaudhary S, Sharma C, Kanakan A, A V, Srinivasa Vasudevan J, Maurya R, Fatihi S, Thukral L, Agrawal A, Pinto L, Pandey R, Sunil S.
PMID: 33768104
Front Med (Lausanne). 2021 Mar 09;8:631769. doi: 10.3389/fmed.2021.631769. eCollection 2021.

No abstract available.

Cite
Shastri J, Parikh S, Agrawal S, et al. Clinical, Serological, Whole Genome Sequence Analyses to Confirm SARS-CoV-2 Reinfection in Patients From Mumbai, India. Front Med (Lausanne). 2021;8:631769doi: 10.3389/fmed.2021.631769.
Shastri, J., Parikh, S., Agrawal, S., Chatterjee, N., Pathak, M., Chaudhary, S., Sharma, C., Kanakan, A., A, V., Srinivasa Vasudevan, J., Maurya, R., Fatihi, S., Thukral, L., Agrawal, A., Pinto, L., Pandey, R., & Sunil, S. (2021). Clinical, Serological, Whole Genome Sequence Analyses to Confirm SARS-CoV-2 Reinfection in Patients From Mumbai, India. Frontiers in medicine, 8631769. https://doi.org/10.3389/fmed.2021.631769
Shastri, Jayanthi, et al. "Clinical, Serological, Whole Genome Sequence Analyses to Confirm SARS-CoV-2 Reinfection in Patients From Mumbai, India." Frontiers in medicine vol. 8 (2021): 631769. doi: https://doi.org/10.3389/fmed.2021.631769
Shastri J, Parikh S, Agrawal S, Chatterjee N, Pathak M, Chaudhary S, Sharma C, Kanakan A, A V, Srinivasa Vasudevan J, Maurya R, Fatihi S, Thukral L, Agrawal A, Pinto L, Pandey R, Sunil S. Clinical, Serological, Whole Genome Sequence Analyses to Confirm SARS-CoV-2 Reinfection in Patients From Mumbai, India. Front Med (Lausanne). 2021 Mar 09;8:631769. doi: 10.3389/fmed.2021.631769. eCollection 2021. PMID: 33768104; PMCID: PMC7985553.
Copy Download .nbib Format: NLM
Fundamentals and applications of analytical chemistry in natural products.

International journal of analytical chemistry

Lopes NP, Pinto E, Niehues M, Gates PJ, Vessecchi R.
PMID: 22888351
Int J Anal Chem. 2012;2012:156201. doi: 10.1155/2012/156201. Epub 2012 Jul 22.

No abstract available.

Cite
Lopes NP, Pinto E, Niehues M, et al. Fundamentals and applications of analytical chemistry in natural products. Int J Anal Chem. 2012;2012:156201doi: 10.1155/2012/156201.
Lopes, N. P., Pinto, E., Niehues, M., Gates, P. J., & Vessecchi, R. (2012). Fundamentals and applications of analytical chemistry in natural products. International journal of analytical chemistry, 2012156201. https://doi.org/10.1155/2012/156201
Lopes, Norberto P, et al. "Fundamentals and applications of analytical chemistry in natural products." International journal of analytical chemistry vol. 2012 (2012): 156201. doi: https://doi.org/10.1155/2012/156201
Lopes NP, Pinto E, Niehues M, Gates PJ, Vessecchi R. Fundamentals and applications of analytical chemistry in natural products. Int J Anal Chem. 2012;2012:156201. doi: 10.1155/2012/156201. Epub 2012 Jul 22. PMID: 22888351; PMCID: PMC3408667.
Copy Download .nbib Format: NLM
BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity.

Molecules (Basel, Switzerland)

Novais P, Silva PMA, Moreira J, Palmeira A, Amorim I, Pinto M, Cidade H, Bousbaa H.
PMID: 34885726
Molecules. 2021 Nov 25;26(23). doi: 10.3390/molecules26237139.

Previously, we reported the in vitro growth inhibitory effect of diarylpentanoid BP-M345 on human cancer cells. Nevertheless, at that time, the cellular mechanism through which BP-M345 exerts its growth inhibitory effect remained to be explored. In the present work,...

Cite
Novais P, Silva PMA, Moreira J, et al. BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity. Molecules. 2021;26(23)doi: 10.3390/molecules26237139.
Novais, P., Silva, P. M. A., Moreira, J., Palmeira, A., Amorim, I., Pinto, M., Cidade, H., & Bousbaa, H. (2021). BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity. Molecules (Basel, Switzerland), 26(23), . https://doi.org/10.3390/molecules26237139
Novais, Pedro, et al. "BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity." Molecules (Basel, Switzerland) vol. 26,23 (2021). doi: https://doi.org/10.3390/molecules26237139
Novais P, Silva PMA, Moreira J, Palmeira A, Amorim I, Pinto M, Cidade H, Bousbaa H. BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity. Molecules. 2021 Nov 25;26(23). doi: 10.3390/molecules26237139. PMID: 34885726; PMCID: PMC8659070.
Copy Download .nbib Format: NLM
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.

Nature

Cameroni E, Bowen JE, Rosen LE, Saliba C, Zepeda SK, Culap K, Pinto D, VanBlargan LA, De Marco A, di Iulio J, Zatta F, Kaiser H, Noack J, Farhat N, Czudnochowski N, Havenar-Daughton C, Sprouse KR, Dillen JR, Powell AE, Chen A, Maher C, Yin L, Sun D, Soriaga L, Bassi J, Silacci-Fregni C, Gustafsson C, Franko NM, Logue J, Iqbal NT, Mazzitelli I, Geffner J, Grifantini R, Chu H, Gori A, Riva A, Giannini O, Ceschi A, Ferrari P, Cippà PE, Franzetti-Pellanda A, Garzoni C, Halfmann PJ, Kawaoka Y, Hebner C, Purcell LA, Piccoli L, Pizzuto MS, Walls AC, Diamond MS, Telenti A, Virgin HW, Lanzavecchia A, Snell G, Veesler D, Corti D.
PMID: 35016195
Nature. 2021 Dec 23; doi: 10.1038/s41586-021-04386-2. Epub 2021 Dec 23.

The recently emerged SARS-CoV-2 Omicron variant encodes 37 amino acid substitutions in the spike (S) protein, 15 of which are in the receptor-binding domain (RBD), thereby raising concerns about the effectiveness of available vaccines and antibody therapeutics. Here, we...

Cite
Cameroni E, Bowen JE, Rosen LE, et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature. 2021;doi: 10.1038/s41586-021-04386-2.
Cameroni, E., Bowen, J. E., Rosen, L. E., Saliba, C., Zepeda, S. K., Culap, K., Pinto, D., VanBlargan, L. A., De Marco, A., di Iulio, J., Zatta, F., Kaiser, H., Noack, J., Farhat, N., Czudnochowski, N., Havenar-Daughton, C., Sprouse, K. R., Dillen, J. R., Powell, A. E., Chen, A., Maher, C., Yin, L., Sun, D., Soriaga, L., Bassi, J., Silacci-Fregni, C., Gustafsson, C., Franko, N. M., Logue, J., Iqbal, N. T., Mazzitelli, I., Geffner, J., Grifantini, R., Chu, H., Gori, A., Riva, A., Giannini, O., Ceschi, A., Ferrari, P., Cippà, P. E., Franzetti-Pellanda, A., Garzoni, C., Halfmann, P. J., Kawaoka, Y., Hebner, C., Purcell, L. A., Piccoli, L., Pizzuto, M. S., Walls, A. C., Diamond, M. S., Telenti, A., Virgin, H. W., Lanzavecchia, A., Snell, G., Veesler, D., & Corti, D. (2021). Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature, . https://doi.org/10.1038/s41586-021-04386-2
Cameroni, Elisabetta, et al. "Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift." Nature vol. (2021). doi: https://doi.org/10.1038/s41586-021-04386-2
Cameroni E, Bowen JE, Rosen LE, Saliba C, Zepeda SK, Culap K, Pinto D, VanBlargan LA, De Marco A, di Iulio J, Zatta F, Kaiser H, Noack J, Farhat N, Czudnochowski N, Havenar-Daughton C, Sprouse KR, Dillen JR, Powell AE, Chen A, Maher C, Yin L, Sun D, Soriaga L, Bassi J, Silacci-Fregni C, Gustafsson C, Franko NM, Logue J, Iqbal NT, Mazzitelli I, Geffner J, Grifantini R, Chu H, Gori A, Riva A, Giannini O, Ceschi A, Ferrari P, Cippà PE, Franzetti-Pellanda A, Garzoni C, Halfmann PJ, Kawaoka Y, Hebner C, Purcell LA, Piccoli L, Pizzuto MS, Walls AC, Diamond MS, Telenti A, Virgin HW, Lanzavecchia A, Snell G, Veesler D, Corti D. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature. 2021 Dec 23; doi: 10.1038/s41586-021-04386-2. Epub 2021 Dec 23. PMID: 35016195.
Copy Download .nbib Format: NLM
Showing 1801 to 1810 of 1810 entries